MindWalk Holdings Corp. (HYFT)

Revenue by Segment

Financials in millions USD. Fiscal year is May - April.

Year Ending	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020	Apr 30, 2019	Apr 30, 2018	Apr 30, 2017	Apr 30, 2016
Antibody Production Project	15.91M
Antibody Production Project Growth	-3.36%
Antibody Production Product	1.51M
Antibody Production Product Growth	0.33%
Cryostorage	170.79K
Cryostorage Growth	-7.01%

Revenue by Geography

Financials in millions USD. Fiscal year is May - April.

Year Ending	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020	Apr 30, 2019	Apr 30, 2018	Apr 30, 2017	Apr 30, 2016
United States	9.05M
United States Growth	-2.65%
Europe	7.30M
Europe Growth	-9.25%
Australia	642.96K
Australia Growth	80.12%
Canada	167.92K
Canada Growth	-41.71%
Other	429.12K
Other Growth	158.68%

Data Source: Finnhub Last updated: Jan 31, 2026

Financial data is provided by Finnhub and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 9, 2026

Data Sources Report a data error